scout
|Videos|November 10, 2018

Immunologic Biomarker Findings for mFOLFOX6 and Pembrolizumab in CRC

Matthew Farren, PhD, post-doctoral fellow, Winship Cancer Institute, Emory University, discusses immunologic biomarker findings in a study of mFOLFOX6 plus pembrolizumab (Keytruda) in colorectal cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME